# OnCo record abbisko (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/abbisko/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "abbisko" ;
  schema:name "Abbisko Therapeutics"@en ;
  schema:alternateName "Abbisko Therapeutics Co, Ltd"@en, "和誉生物"@en ;
  schema:description "Abbisko is a Shanghai biotech listed in Hong Kong whose CSF-1R inhibitor pimicotinib met its phase 3 endpoint in tenosynovial giant cell tumour, a rare joint tumour, and is licensed to Merck KGaA."@en ;
  schema:url <https://onco.cc/companies/abbisko/>, <https://www.abbisko.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.abbisko.com>, <https://clinicaltrials.gov/search?lead=Abbisko%20Therapeutics%20Co%2C%20Ltd>, <https://www.wikidata.org/wiki/Q140045781> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/tenosynovial-giant-cell-tumour/>, <https://onco.cc/cancers/hcc/> ;
  onco:targets <https://onco.cc/targets/csf1r/> ;
  onco:drugs <https://onco.cc/drugs/absk061/>, <https://onco.cc/drugs/pimicotinib/> ;
  onco:companies <https://onco.cc/companies/merck-kgaa/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> ;
  onco:trials <https://onco.cc/trials/nct06632262/>, <https://onco.cc/trials/nct07164170/>, <https://onco.cc/trials/nct06668103/>, <https://onco.cc/trials/nct05804045/>, <https://onco.cc/trials/nct07327034/>, <https://onco.cc/trials/nct06111274/>, <https://onco.cc/trials/nct07417189/> .